CONCENTRA GROUP HOLDINGS PARENT, INC.
In the published model solve dated 2026-Q2, anchored at $34.47, CONCENTRA GROUP HOLDINGS PARENT, INC. (CON) is priced for -1.6% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. The narrative was composed July 25, 2026 from SEC EDGAR filings.
• Concentra operates ⟦628 occupational health center facilities across the United States⟧ plus ⟦411 permanent on-site locations⟧ inside employer workplaces, and it earns a 16.4% trailing operating margin on 2.23 billion dollars of revenue, roughly triple what SEM, the company it was separated from, earns on its own revenue. • Someone else sets the price of most of what it sells: the 10-K lists ⟦Cost containment initiatives or state fee schedule changes undertaken by state workers' compensation b
Is CON overvalued? See what's priced in →
270 institutional managers reported holding CON in 13F filings for the quarter ended 2026-03-31. Together they hold about 82% of the company; the top 10 hold 54%. 42 opened new positions that quarter. Held by BlackRock, T. Rowe Price, Vanguard Group, among others. On the short side, 2.7M shares were sold short as of the 2026-06-15 count, about 2% of shares outstanding (2.9 days of typical volume to cover).
Quarterly 13F filings arrive up to 45 days after quarter end, so the picture is never current (filed through 2026-05-29). Nothing here is investment advice.
It pays a dividend, and has paid one every year in our records (2 and counting); the current rate is $0.25 a share annually. Cash returned over the past three years: $48.05M in dividends and $30.40M in repurchases.
Share counts are split-adjusted; repurchase totals are gross of share issuance. Nothing here is investment advice.
No open-market insider buys on file at CON over the trailing three years. Absence is a fact about the company, not a signal. 20 officers and directors are on file.
Code P open-market purchases from SEC Form 4 filings, non-derivative, excluding scheduled 10b5-1 plans. Nothing here is investment advice.
CON's recent reports: the day-one move, then what the following quarter actually did.
| report | day one | next quarter |
|---|---|---|
| 2024-11-07 | -3.1% | -1.6% |
| 2025-03-04 | -0.5% | -3.5% |
| 2025-05-08 | -2.7% | -3.0% |
| 2025-08-08 | +8.4% | -6.0% |
Day-one is the close-to-close move around the filing. Nothing here is investment advice.
CON's latest 8-K filings: 2026-09-08 (items 5.02, 7.01, 9.01); 2026-08-27 (items 1.01, 9.01); 2026-08-06 (items 2.02, 5.02, 7.01, 8.01, 9.01); 2026-07-10 (items 5.02, 9.01); 2026-05-07 (items 2.02, 7.01, 8.01, 9.01).
Item codes are the SEC's own classification of what each report discloses. Dates link to the filing on EDGAR. Nothing here is investment advice.
Model solve date: 2026-Q2
Narrative composed: July 25, 2026
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.